探索发现新兴毒品趋势的挑战和机遇:加拿大环境的社会技术分析
Etran Bouchouar1, Marissa J Levine2, Samuel Ileka-Priouzeau3
1College of Public Health, University of South Florida, Tampa, FL, USA. Etran.Bouchouar@phac-aspc.gc.ca.
Canadian journal of public health = Revue canadienne de sante publique
|December 29, 2023
概括
系统思维方法揭示了社会,技术和环境因素影响加拿大的国家物质使用预警系统 (EWS). 了解这些相互关联的元素对于有效的公共卫生监测和毒品趋势检测至关重要.
科学领域:
- 公共卫生监督 公共卫生监督
- 系统思维 系统思维
- 药物趋势分析 药物趋势分析
背景情况:
- 新兴的药物趋势构成了重大的公共卫生挑战.
- 现有的监控系统可能无法充分捕捉影响检测的局部因素.
- 一个泛加拿大物质使用预警系统 (EWS) 需要了解省和地区的背景.
研究的目的:
- 应用系统思维方法来确定影响加拿大各省和地区新兴毒品趋势检测的因素.
- 探索当地环境如何影响国家物质使用 EWS 的设计和性能.
- 制定可行的建议,以改进国家EWS.
主要方法:
- 与加拿大各地的13名医疗卫生官员和流行病学家进行了半结构化采访.
- 主题和社交网络分析.
- 社会技术系统框架的应用.
主要成果:
- 发现新兴毒品趋势受到相互关联的社会,技术和外部环境因素的影响.
- 由于系统的缺陷,分散的运营,差的跨部门合作伙伴关系和不可操作的信息是系统缺陷的结果.
- 参与者对国家EWS的看法各不相同,发现了机会和担忧.
结论:
- 相互关联的社会,技术和环境因素对于在加拿大设计和实施国家物质使用ESW至关重要.
- 社会技术系统框架对于理解复杂的公共卫生监测问题是有价值的.
- 这一框架可以为开发更有效的公共卫生战略提供信息,以检测毒品趋势.
相关概念视频
Drug Control Governance: Regulatory Bodies and Their Impact
160
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
160
Pharmacovigilance
838
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
838
Drug Discovery: Overview
7.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.9K
Drug Concentrations: Measurements
375
Drug concentration is the quantity of a drug present in a biological sample. Measuring drug amounts in biological samples allows the clinician to understand how a drug is absorbed, distributed, metabolized, and excreted. Samples can be obtained through invasive or non-invasive methods. Invasive techniques involve surgical or parenteral interventions to gather blood, cerebrospinal fluid, or tissue biopsy. Conversely, non-invasive approaches provide samples like urine, feces, and saliva.
Plasma...
Plasma...
375
Drug Regulation
1.4K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.4K
Structure-Activity Relationships and Drug Design
726
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
726


